ALKS:NASDAQ
Alkermes Plc
$43.39
arrow_downward
-7.11%(-3.32) 1D
Sep 18, 4:00:02 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALKS...
Open
$46.51
High
$46.53
Low
$43.27
Mkt. cap
7.28B
Avg. vol.
1.38M
Volume
0.00
P/E ratio
112.74
52-wk high
$55.67
52-wk low
$26.99
EPS
$0.38
Beta
0.27
Shares outstanding
167.76M
No. of employees
2K
Open
$46.51
High
$46.53
Low
$43.27
Mkt. cap
7.28B
Avg. vol.
1.38M
Volume
0.00
P/E ratio
112.74
52-wk high
$55.67
52-wk low
$26.99
EPS
$0.38
Beta
0.27
Shares outstanding
167.76M
No. of employees
2K
News stories
From web sources and news partners
TipRanks
·
2 days ago
Alkermes Stock Slumps Despite Strong-Buy Upgrade
careplusvn.com
·
3 weeks ago
Alkermes (ALKS) Results at a Glance: Profit Per Share Surpasses Its Benchmark; Market Response: Shares Finish 1.12% Higher in Latest Trading - Annual Financial Report
careplusvn.com
·
1 month ago
Alkermes (ALKS) Shares: Posts a 3.31% Loss to $48.52 for the Current Session
CarePlus VietNam
·
1 month ago
Alkermes (ALKS) Advances 1.53% as Shares Hold Firm Above Key Support - PCR Extreme
Profile
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
About Alkermes Plc
CEORichard F. Pops | Richard F. Pops
Employees2.05K
Founded1987
Headquarters-
SectorBiotechnology
Websitealkermes.com